1. Chemotherapy plus radiotherapy versus radiotherapy alone in patients with anaplastic glioma: a systematic review and meta-analysis

   • Lei Zhang
   • Xiaojun Wu
   • Yicheng Lu

   Review 10 February 2013 Pages: 719 - 726

   

2. Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies

   • Nadège Kindt
   • Julie Preillon
   • Sven Saussez

   Original Paper 25 January 2013 Pages: 727 - 737

   

3. Vimentin as a poor prognostic factor for triple-negative breast cancer

   • Nami Yamashita
   • Eriko Tokunaga
   • Yoshihiko Maehara

   Original Paper 26 January 2013 Pages: 739 - 746

   

4. Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer

   • Dina Schütze
   • Karin Milde-Langosch
   • Volkmar Müller

   Original Paper 29 January 2013 Pages: 747 - 754

   

5. Detection of circulating tumor cells in different stages of prostate cancer

   • Mark Thalgott
   • Brigitte Rack
   • Margitta Retz

   Original Paper 29 January 2013 Pages: 755 - 763

   

6. TNF-β +252 A>G polymorphism and susceptibility to cancer

   • Lin Yang
   • Rennan Feng
   • Wenbo Wang

   Original Paper 03 February 2013 Pages: 765 - 772

   

7. Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection

   • Xiaohong Chen
   • Boheng Zhang
   • Jian Zhou

   Original Paper 03 February 2013 Pages: 773 - 781

   

8. Short-term versus long-term hormone therapy plus radiotherapy or prostatectomy for prostate cancer: a systematic review and meta-analysis

   • Zhi-Rui Zhou
   • Xiao-Dong Zhu
   • Zhong-Guo Liang

   Original Paper 05 February 2013 Pages: 783 - 796

   

9. Celecoxib enhances the efficacy of 15-hydroxyprostaglandin dehydrogenase gene therapy in treating murine breast cancer

   • Binglan Zhang
   • Xuelei Ma
   • Yuquan Wei

   Original Paper 06 February 2013 Pages: 797 - 807

   

10. Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers

    • Isabell Witzel
    • Monika Graeser
    • Volkmar Müller

    Original Paper 08 February 2013 Pages: 809 - 816

    

11. Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component

    • Inkeun Park
    • Yong Mee Cho
    • Hanjong Ahn

    Original Paper 09 February 2013 Pages: 817 - 827

    

12. Bevacizumab plus irinotecan in recurrent or progressive malign glioma: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)

    • Umut Demirci
    • Gulnihal Tufan
    • Mustafa Benekli

    Original Paper 12 February 2013 Pages: 829 - 835

    

13. Insulin-like growth factor 1 and musculoskeletal pain among breast cancer patients on aromatase inhibitor therapy and women without a history of cancer

    • Lisa Gallicchio
    • Ryan MacDonald
    • Kathy J. Helzlsouer

    Original Paper 14 February 2013 Pages: 837 - 843

14. Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test

    • Yusuke Suzuki
    • Kenji Imai
    • Hisataka Moriwaki

    Original Paper 15 February 2013 Pages: 845 - 852

    

15. Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis

    • T. Gamucci
    • A. Vaccaro
    • P. Vici

    Original Paper Open access 15 February 2013 Pages: 853 - 860

    

16. Simultaneous activation of T helper function can augment the potency of dendritic cell-based cancer immunotherapy

    • Koji Teramoto
    • Yasuhiko Ohshio
    • Keiichi Kontani

    Original Paper 15 February 2013 Pages: 861 - 870

    

17. Laparoscopic radical prostatectomy plus extended lymph nodes dissection for cases with non-extra node metastatic prostate cancer: 5-year experience in a single Chinese institution

    • Ming-Kun Chen
    • Yun Luo
    • Xin Gao

    Original Paper 16 February 2013 Pages: 871 - 878

    

18. Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer

    • Kiyoshi Misawa
    • Takeharu Kanazawa
    • Hiroyuki Mineta

    Original Paper 19 February 2013 Pages: 879 - 889

    

19. PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis

    • Shuangjie Wu
    • Yu Gan
    • Yifan Tang

    Original Paper 24 February 2013 Pages: 891 - 900